Snowball logo
logo
BIOR

BIORQ

BIORQ • PINK
$0.0001$0.00  (0%)
Estimate
EPS
-0.01
Beta
159.564
About the company
Ticker
BIORQ
ISIN
US74319F4046
Country
United States of America
Sector (GICS)
Other
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California. On May 27, 2025, the voluntary petition of Biora Therapeutics, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on December 27, 2024.

Frequently asked questions

What sector does BIORQ (BIORQ) operate in?

BIORQ belongs to the Other sector and operates in the Biotechnology industry.

What is BIORQ (BIORQ) current stock price?

As of the latest data, BIORQ stock price is $0.00, with a previous close of $0.00.

What is BIORQ (BIORQ) current market capitalization?

BIORQ market cap is approximately 452.27.

What is BIORQ (BIORQ) Earnings Per Share (EPS)?

The trailing EPS is -$0.01.

Does BIORQ (BIORQ) pay dividends?

No. BIORQ does not pay a dividend.

What is BIORQ (BIORQ) beta (volatility) score?

BIORQ has a beta of 159.564, indicating very high volatility compared to the market.